Page last updated: 2024-10-20

thiamine and Tauopathies

thiamine has been researched along with Tauopathies in 1 studies

thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.

Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tapias, V1
Jainuddin, S1
Ahuja, M1
Stack, C1
Elipenahli, C1
Vignisse, J1
Gerges, M1
Starkova, N1
Xu, H1
Starkov, AA1
Bettendorff, L1
Hushpulian, DM1
Smirnova, NA1
Gazaryan, IG1
Kaidery, NA1
Wakade, S1
Calingasan, NY1
Thomas, B1
Gibson, GE1
Dumont, M1
Beal, MF1

Other Studies

1 other study available for thiamine and Tauopathies

ArticleYear
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
    Human molecular genetics, 2018, 08-15, Volume: 27, Issue:16

    Topics: Amyloid beta-Peptides; Animals; Antioxidant Response Elements; Brain; Disease Models, Animal; Humans

2018